Paragon Care Ltd (ASX:PGC)
A$ 0.14 +0.0050 (+3.85%) Market Cap: 223.47 Mil Enterprise Value: 590.55 Mil PE Ratio: 0 PB Ratio: 0.74 GF Score: 53/100

Half Year 2026 Paragon Care Ltd Earnings Call Transcript

Feb 25, 2026 / 01:00AM GMT
Release Date Price: A$0.18 (-12.20%)

Key Points

Positve
  • Paragon Care Ltd (ASX:PGC) reported strong underlying revenue of $1.9 billion and an underlying EBITDA of $49 million, indicating solid performance despite challenges.
  • The company successfully managed to recover $78 million in revenue lost due to the Infinity Group issue, showcasing resilience and effective management.
  • Paragon Care Ltd (ASX:PGC) achieved significant contract wins, including a five-year contract with the Australian Defence Force, highlighting its capability and competitive edge.
  • The company reported strong growth in its Asia segment, with revenue growth of 33.2% and a margin of 44%, demonstrating successful expansion efforts in the region.
  • Paragon Care Ltd (ASX:PGC) maintained solid margins and managed expenses well, despite challenges such as freight costs and integration expenses.
Negative
  • The statutory EBITDA showed a loss of $0.4 million, primarily due to the full provision for the Infinity Group debt, which remains a significant financial burden.
  • The company experienced delays and challenges in its integration strategy, particularly affecting freight costs and the opening of the new Brisbane site.
  • Paragon Care Ltd (ASX:PGC) faced a decline in its MedTech segment, particularly in the vision area, which impacted overall performance.
  • The company did not declare a dividend for the period, which may concern shareholders looking for immediate returns.
  • Paragon Care Ltd (ASX:PGC) is dealing with elevated net debt levels, partly due to the unresolved Infinity Group debt, which could impact future financial flexibility.
Operator

Thank you for standing by and welcome to the Paragon Care 180 H26 results briefing. All participants are in listen-only mode. There will be a presentation followed by a question-and-answer session.

(Operator Instructions).

I would now like to hand the conference over to Carmen Riley, CEO. Please go ahead.

Carmen Riley
Paragon Care Ltd - Chief Executive Officer, Executive Director

Okay, great. Thanks, Harmony. Thanks everyone for joining the call today. I'm here with Brendon Pentland. For those who haven't met him yet, he's our new CFO, that's been on board for a couple of months. So, I'll go through the high level at the moment, and then I'll hand over to Brendon for the detail.

But just turning over you can see our underlying result is sitting at good sales at $1.9 billion our underlying EBITDA at $49 million which I think is a good solid result, net profit after tax at $13.3 million. So, on the statutory result, revenue remains the same. EBITDA is a loss of 4,000 and net loss after tax of $21.3 million.

So just to go

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot